CRISM Therapeutics Corporation (AIM: CRTX)
Health Care · Biotechnology · VG
£0.09
-5.13% today · -15.9% 1Y
CRISM Therapeutics Corporation (AIM: CRTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.69M.
Over the last twelve months the share price has lost 15.9%, trading between 0.08 and 0.19.
Tweenvest scores CRISM Therapeutics Corporation across four factors: quality 36/100, value 61/100. Its strongest factor is value.
CRTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.69M
- Revenue (TTM)
- $467.03K
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- £0.19
- 52-week low
- £0.08
- Avg volume (3M)
- —
- Shares outstanding
- 79.19M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $10.04M | $0.32 | -0.19% |
| Active Biotech AB (publ)OM: ACTI | $9.96M | Skr3.79 | -10.82% |
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $9.81M | $0.04 | +45.10% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $9.80M | $1.25 | -8.09% |
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | $9.61M | $0.02 | -17.00% |
| NFL Biosciences SAENXTPA: ALNFL | $9.54M | €0.67 | -10.32% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $9.48M | $0.42 | -12.90% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
Figures last refreshed Oct 4, 2026.